Apotex Health Corp. AOTXF
OTC PK
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Net Income | -110.57% | ||||
| Total Depreciation and Amortization | 34.81% | ||||
| Total Amortization of Deferred Charges | -18.41% | ||||
| Total Other Non-Cash Items | 141.67% | ||||
| Change in Net Operating Assets | -147.62% | ||||
| Cash from Operations | -92.80% | ||||
| Capital Expenditure | -92.84% | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -62.39% | ||||
| Cash from Investing | -79.94% | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -1,415.30% | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | 516.49% | ||||
| Foreign Exchange rate Adjustments | 166.13% | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -35.38% | ||||